COASY and Alzheimer disease: Recently, some studies have correlated the COASY gene promoter methylation with the pathophysiology of Alzheimer’s disease (AD) and amnestic mild cognitive impairment (aMCI), indicating that this parameter could be a useful blood prodromic biomarker [113,114].